J. Hammer

发表

Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning

Z. Nagy, F. Sinigaglia, E. Bono, 1994, The Journal of experimental medicine.

Rules for peptide binding to MHC class II molecules

F. Sinigaglia, J. Hammer, J. Hammer, 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Antigen Recognition and Autoimmunity

F. Sinigaglia, J. Hammer, 1999 .

Antigenic peptides and autoimmunity

F. Sinigaglia, T. Sturniolo, L. Raddrizzani, 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Protein Selected by the TEPITOPE Program Melanoma-Associated Glycoprotein 100 Response Toward Peptides of the In Vitro and In Vivo Induction of a Th Cell

M. Zöller, L. Raddrizzani, J. Hammer, 2000 .

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis

F. Falcioni, Z. Nagy, D. Bolin, 1996, The Journal of experimental medicine.

T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1.

M. Zöller, L. Raddrizzani, J. Hammer, 2001, Immunobiology.

Data cleansing for computer models: a case study from immunology

Vladimir Brusic, John Zeleznikow, T. Sturniolo, 1999, ICONIP'99. ANZIIS'99 & ANNES'99 & ACNN'99. 6th International Conference on Neural Information Processing. Proceedings (Cat. No.99EX378).

Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer

M. W. Büchler, H. Friess, J. Kleeff, 2003, Cellular and Molecular Life Sciences CMLS.

Identification of a motif for HLA-DR1 binding peptides using M13 display libraries

F. Sinigaglia, B. Takács, J. Hammer, 1992, The Journal of experimental medicine.

A novel approach to human anti-HLA mABs production: use of phage display libraries.

G. Ferrara, M. Pistillo, F. Sinigaglia, 1997, Human immunology.

HLA class II peptide binding specificity and autoimmunity.

F. Sinigaglia, T. Sturniolo, J. Hammer, 1997, Advances in immunology.

Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules

J. Guenot, S. Berthel, F. Falcioni, 1999, Nature Biotechnology.

In Silico Prediction of Peptides Binding to Multiple HLA-DR Molecules Accurately Identifies Immunodominant Epitopes from gp43 of Paracoccidioides brasiliensis Frequently Recognized in Primary Peripheral Blood Mononuclear Cell Responses from Sensitized Individuals

J. Sidney, A. Sette, L. Juliano, 2003, Molecular medicine.

Motifs and supermotifs for MHC class II binding peptides

F. Sinigaglia, J. Hammer, F Sinigaglia, 1995, The Journal of experimental medicine.

New methods to predict MHC-binding sequences within protein antigens.

J. Hammer, J Hammer, 1995, Current opinion in immunology.

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

R. Karr, J. Guenot, Z. Nagy, 1995, The Journal of experimental medicine.

Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma

H. Friess, J. Kleeff, T. Giese, 2004, Oncogene.

In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program1

L Raddrizzani, M. Zöller, L. Raddrizzani, 2000, The Journal of Immunology.

HLA Class I Molecules Human Transporters Associated with Antigen Relationship Between Peptide Selectivities of

V. Brusic, L. Harrison, D. Riganelli, 1998 .

A neural network model approach to the study of human TAP transporter

Vladimir Brusic, John Zeleznikow, Nikolai Petrovsky, 1998, Silico Biol..

Defining rules for the peptide-MHC class II interaction.

F. Sinigaglia, J. Hammer, J. Hammer, 1994, Current opinion in immunology.

Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network

Vladimir Brusic, Jürgen Hammer, G. Honeyman, 1998, Bioinform..

Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.

L Raddrizzani, J. Guenot, Z. Nagy, 1997, Journal of immunology.

High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

R. Walsky, Z. Nagy, F. Sinigaglia, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Role of Mononuclear Cells and Inflammatory Cytokines in Pancreatic Cancer-Related Cachexia

Helmut Friess, H. Friess, T. Giese, 2005, Clinical Cancer Research.

Identification of Disease-specific Genes in Chronic Pancreatitis Using DNA Array Technology

H. Friess, J. Kleeff, P. Berberat, 2001, Annals of surgery.

Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.

F. Sinigaglia, E. Nardin, J. Hammer, 1997, Journal of immunology.

Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract.

H. Friess, H. Kayed, J. Kleeff, 2004, Histology and histopathology.

Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules.

V Brusic, N Petrovsky, N. Petrovsky, 1998, Journal of immunology.

Expression analysis of MAC 30 in human pancreatic cancer and tumors of the gastrointestinal tract

H. Friess, H. Kayed, J. Kleeff, 2004 .